Annual EBIT
-$211.50 M
-$15.37 M-7.84%
31 December 2023
Summary:
Adaptive Biotechnologies annual earnings before interest & taxes is currently -$211.50 million, with the most recent change of -$15.37 million (-7.84%) on 31 December 2023. During the last 3 years, it has fallen by -$58.69 million (-38.40%). ADPT annual EBIT is now -384.71% below its all-time high of -$37.84 million.ADPT EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly EBIT
-$29.16 M
+$14.39 M+33.05%
30 September 2024
Summary:
Adaptive Biotechnologies quarterly earnings before interest & taxes is currently -$29.16 million, with the most recent change of +$14.39 million (+33.05%) on 30 September 2024. Over the past year, it has increased by +$17.52 million (+37.53%). ADPT quarterly EBIT is now -218.28% below its all-time high of -$9.16 million, reached on 30 September 2018.ADPT Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM EBIT
-$183.71 M
+$17.52 M+8.70%
30 September 2024
Summary:
Adaptive Biotechnologies TTM earnings before interest & taxes is currently -$183.71 million, with the most recent change of +$17.52 million (+8.70%) on 30 September 2024. Over the past year, it has dropped by -$2.07 million (-1.14%). ADPT TTM EBIT is now -1298.27% below its all-time high of -$13.14 million, reached on 31 March 2018.ADPT TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ADPT EBIT Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -7.8% | +37.5% | -1.1% |
| 3 y3 years | -38.4% | +47.9% | +4.0% |
| 5 y5 years | -325.1% | -61.5% | -168.8% |
ADPT EBIT High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -38.4% | at low | at high | +56.1% | -2.3% | +20.9% |
| 5 y | 5 years | -325.1% | at low | -61.5% | +56.1% | -168.8% | +20.9% |
| alltime | all time | -384.7% | at low | -218.3% | +56.1% | -1298.3% | +20.9% |
Adaptive Biotechnologies EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$29.16 M(-33.1%) | -$183.71 M(-8.7%) |
| June 2024 | - | -$43.55 M(-2.2%) | -$201.22 M(-0.3%) |
| Mar 2024 | - | -$44.54 M(-33.0%) | -$201.88 M(-4.6%) |
| Dec 2023 | -$211.50 M(+7.8%) | -$66.45 M(+42.4%) | -$211.50 M(+16.4%) |
| Sept 2023 | - | -$46.67 M(+5.6%) | -$181.63 M(+1.1%) |
| June 2023 | - | -$44.21 M(-18.4%) | -$179.63 M(-4.2%) |
| Mar 2023 | - | -$54.17 M(+48.1%) | -$187.50 M(-4.4%) |
| Dec 2022 | -$196.13 M(-5.4%) | -$36.58 M(-18.1%) | -$196.13 M(-11.2%) |
| Sept 2022 | - | -$44.67 M(-14.2%) | -$220.90 M(-4.9%) |
| June 2022 | - | -$52.08 M(-17.1%) | -$232.24 M(+1.0%) |
| Mar 2022 | - | -$62.80 M(+2.3%) | -$229.92 M(+10.3%) |
| Dec 2021 | -$207.30 M | -$61.36 M(+9.6%) | -$208.40 M(+8.9%) |
| Sept 2021 | - | -$56.00 M(+12.5%) | -$191.28 M(+11.0%) |
| June 2021 | - | -$49.77 M(+20.6%) | -$172.33 M(+8.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2021 | - | -$41.28 M(-6.7%) | -$159.48 M(+4.4%) |
| Dec 2020 | -$152.82 M(+94.9%) | -$44.24 M(+19.4%) | -$152.82 M(+15.1%) |
| Sept 2020 | - | -$37.05 M(+0.4%) | -$132.77 M(+16.7%) |
| June 2020 | - | -$36.91 M(+6.6%) | -$113.77 M(+22.4%) |
| Mar 2020 | - | -$34.62 M(+43.1%) | -$92.97 M(+18.6%) |
| Dec 2019 | -$78.39 M(+57.6%) | -$24.19 M(+34.0%) | -$78.39 M(+14.7%) |
| Sept 2019 | - | -$18.05 M(+12.1%) | -$68.35 M(+15.0%) |
| June 2019 | - | -$16.11 M(-19.7%) | -$59.45 M(+4.9%) |
| Mar 2019 | - | -$20.05 M(+41.7%) | -$56.66 M(+13.9%) |
| Dec 2018 | -$49.76 M(+14.0%) | -$14.14 M(+54.4%) | -$49.76 M(+39.7%) |
| Sept 2018 | - | -$9.16 M(-31.2%) | -$35.61 M(+34.6%) |
| June 2018 | - | -$13.31 M(+1.3%) | -$26.45 M(+101.3%) |
| Mar 2018 | - | -$13.14 M | -$13.14 M |
| Dec 2017 | -$43.63 M | - | - |
FAQ
- What is Adaptive Biotechnologies annual earnings before interest & taxes?
- What is the all time high annual EBIT for Adaptive Biotechnologies?
- What is Adaptive Biotechnologies annual EBIT year-on-year change?
- What is Adaptive Biotechnologies quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for Adaptive Biotechnologies?
- What is Adaptive Biotechnologies quarterly EBIT year-on-year change?
- What is Adaptive Biotechnologies TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for Adaptive Biotechnologies?
- What is Adaptive Biotechnologies TTM EBIT year-on-year change?
What is Adaptive Biotechnologies annual earnings before interest & taxes?
The current annual EBIT of ADPT is -$211.50 M
What is the all time high annual EBIT for Adaptive Biotechnologies?
Adaptive Biotechnologies all-time high annual earnings before interest & taxes is -$37.84 M
What is Adaptive Biotechnologies annual EBIT year-on-year change?
Over the past year, ADPT annual earnings before interest & taxes has changed by -$15.37 M (-7.84%)
What is Adaptive Biotechnologies quarterly earnings before interest & taxes?
The current quarterly EBIT of ADPT is -$29.16 M
What is the all time high quarterly EBIT for Adaptive Biotechnologies?
Adaptive Biotechnologies all-time high quarterly earnings before interest & taxes is -$9.16 M
What is Adaptive Biotechnologies quarterly EBIT year-on-year change?
Over the past year, ADPT quarterly earnings before interest & taxes has changed by +$17.52 M (+37.53%)
What is Adaptive Biotechnologies TTM earnings before interest & taxes?
The current TTM EBIT of ADPT is -$183.71 M
What is the all time high TTM EBIT for Adaptive Biotechnologies?
Adaptive Biotechnologies all-time high TTM earnings before interest & taxes is -$13.14 M
What is Adaptive Biotechnologies TTM EBIT year-on-year change?
Over the past year, ADPT TTM earnings before interest & taxes has changed by -$2.07 M (-1.14%)